Market Exclusive

Analyst Downgrades – NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI) Stock Gets Downgraded By Wedbush from Outperform ➝ Neutral to

Analyst Ratings For NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI)

Today, NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI) stock was downgraded by Wedbush from Outperform ➝ Neutral to .

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI)
NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI) has insider ownership of 13.26% and institutional ownership of 61.44%.

Recent Trading Activity for NASDAQ:KPTI – Karyopharm Therapeutics (NASDAQ:KPTI)
Shares of NASDAQ:KPTI – Karyopharm Therapeutics closed the previous trading session at 17.87 (6.24%)
24 مايو 10:01 ص غرينتش-4إخلاء المسؤولية
 + with 16.809999465942383 shares trading hands.

Exit mobile version